Tsinghua University

Gp Medical, Inc.

Fang Yi Su

Hosheng Tu

Hsing-Wen Sung

Ha Giang Thi Nguyen

Er-Yuan Chuang

Kiran Sonaje

Ho-Ngoc Nguyen

Zi-Xian Liao

Li-Wen Hsu

Er-Yuan Chung

The invention discloses a pharmaceutical composition of nanoparticles consisting of chitosan, a negatively charged substrate, and at least one bioactive agent that is encapsulated within cucurbiturils for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.

Pharmaceutical composition of nanoparticles

The invention discloses a composition of nanoparticles composed of positively charged chitosan, one negatively charged substrate, and optionally a zero-charge compound or at least one tumor necrosis factor inhibitor for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.

The invention discloses a composition of chitosan-shelled nanoparticles and methods of manufacturing. The chitosan-shelled nanoparticles are characterized with a positive surface charge and enhanced epithelial permeability for oral drug delivery.

The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent, wherein the bioactive agent may include mitofusin 1, mitofusin 2, and/or anti-diabetic compounds.

Growing community of inventors

Hsinchu, Taiwan

Fang Yi Su